Douxo Chlorhexidine Micro-Emulsion Spray

Verify with FDA CVM →

36 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
36
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Douxo Chlorhexidine Micro-Emulsion Spray

Administration Routes

TopicalUnknownOphthalmic

Species Affected

Dog 35
Human 1

Most Affected Breeds

Crossbred Canine/dog 6
Retriever - Golden 3
Dog (unknown) 3
Shepherd Dog - German 2
Pekingese 2
Terrier (unspecified) 2
Retriever - Labrador 2
Terrier - Yorkshire 1
Havanese 1
Pointing Dog - Hungarian Short-haired (Vizsla) 1

Most Reported Reactions

Application site erythema 18
Application site pruritus 4
Application site reddening 3
Application site inflammation 3
Diarrhoea 2
Peeling skin 2
Emesis 2
Loose stool 2
Application site irritation 2
Application site swelling 2
Application site pain 2
Lack of efficacy - NOS 2

Outcome Breakdown

Recovered/Normal
17 (47.2%)
Ongoing
14 (38.9%)
Outcome Unknown
5 (13.9%)

Data Summary

Metric Value
Total adverse event reports 36
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Douxo Chlorhexidine Micro-Emulsion Spray Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 36 adverse event reports referencing Douxo Chlorhexidine Micro-Emulsion Spray, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Douxo Chlorhexidine Micro-Emulsion Spray. Reported administration routes include Topical, Unknown, Ophthalmic. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Douxo Chlorhexidine Micro-Emulsion Spray reports are Dog (35 reports), Human (1 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (6), Retriever - Golden (3), Dog (unknown) (3) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Douxo Chlorhexidine Micro-Emulsion Spray are Application site erythema (18), Application site pruritus (4), Application site reddening (3), Application site inflammation (3). Of the 36 reports with a coded outcome, Recovered/Normal is the leading category at 47.2%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Douxo Chlorhexidine Micro-Emulsion Spray.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial